Sinopep-Allsino Bio Pharmaceutical Co.,Ltd.
SHH: 688076.SS0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Shanghai Stock Exchange
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Ziquan Tong
- Employees
- 1,545
- Headquarters
- Hangzhou, China
- IPO year
- 2021
- Market cap
- CN¥10.1B
- Website
- https://www.sinopep.com.cn
Loading 688076…
Loading profile data…Frequently asked questions about 688076
What does Sinopep-Allsino Bio Pharmaceutical Co.,Ltd. (688076.SS) do?
Sinopep-Allsino Bio Pharmaceutical Co.,Ltd., a biomedical company, engages in the research and development, production, sale, and technical service of peptides and small molecule drugs in China. The company offers formulations, such as thymalfasin products for injection, eptifibatide injections, alogliptin benzoate tablets, and oseltamivir phosp...
Where does 688076.SS trade?
Sinopep-Allsino Bio Pharmaceutical Co.,Ltd. (688076.SS) trades on the Shanghai Stock Exchange.
What sector is 688076.SS in?
Sinopep-Allsino Bio Pharmaceutical Co.,Ltd. (688076.SS) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Sinopep-Allsino Bio Pharmaceutical Co.,Ltd.?
Ziquan Tong is the chief executive officer of Sinopep-Allsino Bio Pharmaceutical Co.,Ltd. (688076.SS).
Where is Sinopep-Allsino Bio Pharmaceutical Co.,Ltd. headquartered?
Sinopep-Allsino Bio Pharmaceutical Co.,Ltd. is headquartered in China.
Does 688076.SS pay a dividend?
Yes — Sinopep-Allsino Bio Pharmaceutical Co.,Ltd. (688076.SS) paid a trailing twelve-month dividend of CNY 0.57 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 688076.SS go public?
Sinopep-Allsino Bio Pharmaceutical Co.,Ltd. (688076.SS) completed its initial public offering in 2021.